In 2023, the FDA designated BPC-157 as a Category 2 bulk drug substance, i.e., its evidence to establish safety for human use is currently insufficient
Frequently Asked Questions CB12 Injection is typically recommended for individuals with pernicious anemia, gastrointestinal disorders (like Crohns or celiac disease), or those who have undergone gastric surgery, where B12 absorption from food or oral supplements is impaired
Domestic production allows Limitless Life to maintain low prices on top-quality peptides
In preclinical models, these mechanisms translate into broad potential applications, including wound healing, muscle and tendon repair, gastrointestinal ulcer protection, and recovery from NSAID-induced damage
Some individuals notice effects within hours or days, while others may experience more gradual benefits over weeks
May improve lipid processing in fat cells